Musk says Neuralink’s next frontier is sight for the blind

Signals Inbox·July 24, 2026·NeuroTech

Neuralink says restoring sight is next, including for people who have never seen before. The bigger tension is that artificial vision has already reached the European market through a former Neuralink co-founder, while Neuralink’s more ambitious brain-first approach has yet to produce human vision data.

Q1What is Neuralink officially building?

Neuralink calls the system Blindsight. A camera would capture the outside world, process the images, and send signals wirelessly to an implant in the visual cortex. Instead of repairing the eye, it tries to write visual information directly into the brain.

Q2Why is this different from a bionic eye?

Most bionic eyes still depend on part of the eye and its connection to the brain working. Neuralink wants to bypass the eyes and optic nerves completely. In theory, that gives it a much wider target group, including people whose blindness cannot be fixed at the retina.

Q3Has anyone already restored useful sight?

Yes, but through a narrower approach. Science Corporation’s Prima retinal implant received European clearance in July 2026. In its study, 84% of 38 patients could read letters or numbers. The system only produces a small black-and-white field of vision, but it is moving toward real commercial patients.

Q4Why does that put pressure on Neuralink?

Science Corporation was founded by former Neuralink co-founder Max Hodak. His company now has the clearer near-term product: a retinal implant for a specific form of age-related blindness. Neuralink is chasing the bigger prize, but it still needs to show that direct brain stimulation can create useful and stable human vision.

Q5Is Blindsight approved for patients?

No. The FDA gave Blindsight Breakthrough Device designation in 2024, which can speed communication and review. It is not an approval and does not prove that the device works. Neuralink’s own site still describes its human visual-prosthesis trials as future trials.

Q6What would people actually see?

Probably not normal vision at first. Early cortical implants usually create small points or patterns of light called phosphenes. The real challenge is turning hundreds or thousands of those points into stable shapes, movement, navigation, faces, and eventually readable text.

Q7So what is the real signal?

Neuralink is moving beyond controlling computers and toward replacing a human sense. But the race is no longer theoretical. A competing retinal system has reached European clearance, so Neuralink now has to prove that its riskier brain-first route can deliver broader and better vision, not just a more dramatic promise.